Navigation Links
Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Date:6/11/2013

LEXINGTON, Massachusetts, June 11, 2013 /PRNewswire/ --


Shire's Chief Financial Officer, Graham Hetherington will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12th at 9:20 AM PT /17:20 BST. Investors may access a live audio webcast of the presentation at http://www.shire.com/shireplc/en/investors.

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

http://www.shire.com

For further information please contact:

Investor Relations:

Souheil Salah, ssalah@shire.com, +44-1256-894160

Erin K. Kelly, erikelly@shire.com, +1-781-482-9541


'/>"/>
SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
2. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
3. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
4. Shire Reaches Agreement in Principle With U.S. Government
5. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. Shire Changes its NASDAQ Ticker Symbol to SHPG
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
10. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
11. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , the leading ... the world, was today awarded the "Best Science & Technology Social Networking Service ... and decided upon by a dedicated team of researchers and analysts. , The ...
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... , Jan. 18, 2017 BD (Becton, Dickinson and ... announced today that it will host a live webcast of its ... p.m. (ET). The webcast can be accessed from ... for replay through Tuesday, January 31, 2017. ... About BD BD is a ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
Breaking Biology Technology:
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... -- "Increase in mobile transactions is driving the growth ... is expected to grow from USD 4.03 billion in ... CAGR of 29.3% between 2016 and 2022. The market ... for smart devices, government initiatives, and increasing penetration of ... expected to grow at a high rate during the ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):